Zamann Pharma Support offers expert consulting services to help pharmaceutical companies create a comprehensive strategy for managing Nitrosamines in accordance with ICH M7 and FDA regulations. Our service includes developing structured plans, documentation, and quality procedures that are both scientifically sound and regulatory-compliant. We work closely with client teams to ensure that each element of nitrosamine risk management is tailored to specific product profiles, manufacturing processes, and material risks. Our goal is to build a proactive, audit-ready strategy that supports compliance, protects patient safety, and integrates seamlessly into your organization’s Quality Management System.
As part of our Nitrosamines strategy services, we design a custom risk assessment framework built around ICH M7 methodologies and industry best practices. This framework is tailored to the client’s unique raw materials, synthetic processes, formulation types, and packaging systems. We use predictive modeling, impurity pathway analysis, and structure-activity relationships to identify potential nitrosamine risks and assign severity ratings. Our system supports clear decision-making, audit traceability, and lifecycle integration of impurity control measures. This framework not only enables regulatory alignment but also equips clients with the tools needed for real-time risk prioritization and control.
An essential component of managing Nitrosamines involves standardized operating procedures (SOPs) for identification, quantification, and mitigation. We create clear and validated SOPs that address each stage—from analytical method execution to documentation of findings and control strategies. Our consultants work directly with client QA and RA teams to ensure every SOP meets regulatory requirements under ICH M7 and FDA frameworks. These SOPs are customized to existing systems, easy to implement, and scalable across manufacturing sites. We also provide training guidance and rollout support to ensure a smooth transition and consistent operational adherence.
To support full regulatory compliance on Nitrosamines, we offer documentation review and compliance checks across your existing quality systems. This includes reviewing validation reports, analytical method summaries, risk assessments, and historical batch records. Our team identifies discrepancies, outdated formats, or missing controls that may lead to inspection findings. We then recommend targeted corrective actions and documentation updates, ensuring alignment with current ICH M7 and FDA nitrosamine standards. Our service provides you with a gap-closure roadmap and ensures your documentation package is complete, defendable, and ready for regulatory or internal audits.
Our strategic approach to ensure Nitrosamine compliance is based on global and holistic experience, and can be perfectly adapted to your reality. We address the latest regulations and risk assessments, helping you manage and mitigate potential risks specific to your products and processes.
Zamann stays ahead of the evolving Nitrosamine requirements, providing expert guidance to ensure compliance with confidence. Our proactive and senior approach helps protect product integrity and patient safety, securing your operations against regulatory risks.
